CEO Kersten Geert R Buys 100k CEL‑SCI Shares, Signals Confidence Amid Market Volatility
CEO Kersten Geert R’s latest 100,000‑share buy shows bullish confidence in CEL‑SCI’s immunotherapy pipeline amid a volatile market.
3 minutes to read
CEL - SCI CORP